Interleukin 8 in human hepatocellular carcinoma correlates with cancer cell invasion of vessels but not with tumor angiogenesis

被引:102
作者
Kubo, F [1 ]
Ueno, S [1 ]
Hiwatashi, K [1 ]
Sakoda, M [1 ]
Kawaida, K [1 ]
Nuruki, K [1 ]
Aikou, T [1 ]
机构
[1] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Surg Oncol & Digest Surg, Course Adv Therapeut,Field Oncol, Kagoshima 8908520, Japan
基金
日本学术振兴会;
关键词
interleukin; 8; hepatocellular carcinoma; tumor progression; angiogenesis; chemotaxis; vessel invasion;
D O I
10.1245/ASO.2005.07.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background: Angiogenic factor seems necessary for the development of hepatocellular carcinoma (HCC), which is a hypervascular malignancy. This study examined the expression of interleukin (IL)-8, a potent angiogenic factor, in HCC samples. Methods: We measured IL-8 expression by using reverse transcriptase-polymerase chain reaction in clinical HCC tissues from 45 patients who underwent surgical resection. We then assessed correlations between IL-8 expression and microvessel growth or clinicopathologic factors. We also elucidated the in vitro effect of IL-8 on HepG2 development by using fluorometric assays of proliferation, chemotaxis, and invasion. Results: The expression of IL-8 did not significantly correlate with the microvessel count in HCC tissues, but the incidence of microscopic vessel invasion was significantly higher in IL-8-positive than in IL-8-negative tissues. Thus, more IL-8 was expressed in HCCs at pathologic stage III/IV than in those at stage I/II. Assays in vitro showed that IL-8 stimulates HepG2 chemotactic and invasive activities rather than cell proliferation. Conclusions: The expression of IL-8 in human HCC has more relevance to metastatic potential, such as vessel invasion, than to angiogenesis or cell proliferation.
引用
收藏
页码:800 / 807
页数:8
相关论文
共 29 条
[1]
Akiba J, 2001, INT J ONCOL, V18, P257
[2]
Role of interleukin-8 in tumor growth and metastasis of human melanoma [J].
Bar-Eli, M .
PATHOBIOLOGY, 1999, 67 (01) :12-18
[3]
MICROVESSEL QUANTITATION AND PROGNOSIS IN INVASIVE BREAST-CARCINOMA [J].
BOSARI, S ;
LEE, AKC ;
DELELLIS, RA ;
WILEY, BD ;
HEATLEY, GJ ;
SILVERMAN, ML .
HUMAN PATHOLOGY, 1992, 23 (07) :755-761
[4]
Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver [J].
El-Assal, ON ;
Yamanoi, A ;
Soda, Y ;
Yamaguchi, M ;
Igarashi, M ;
Yamamoto, A ;
Nabika, T ;
Nagasue, N .
HEPATOLOGY, 1998, 27 (06) :1554-1562
[5]
THE IMPLICATIONS OF ANGIOGENESIS FOR THE BIOLOGY AND THERAPY OF CANCER METASTASIS [J].
FIDLER, IJ ;
ELLIS, LM .
CELL, 1994, 79 (02) :185-188
[6]
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
[7]
WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT [J].
FOLKMAN, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01) :4-6
[8]
Clinical implications of expression of interleukin-8 related to myometrial invasion with angiogenesis in uterine endometrial cancers [J].
Fujimoto, J ;
Aoki, I ;
Khatun, S ;
Toyoki, H ;
Tamaya, T .
ANNALS OF ONCOLOGY, 2002, 13 (03) :430-434
[9]
PEA3 and AP-1 are required for constitutive IL-8 gene expression in hepatoma cells [J].
Iguchi, A ;
Kitajima, I ;
Yamakuchi, M ;
Ueno, S ;
Aikou, T ;
Kubo, T ;
Matsushima, K ;
Mukaida, N ;
Maruyama, I .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (01) :166-171
[10]
Inoue K, 2000, CLIN CANCER RES, V6, P2104